SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
¿Cuál es el ratio P/E de SANUWAVE Health Inc (SNWV)?
El ratio P/E de SANUWAVE Health Inc es 13.6046
¿Quién es el CEO de SANUWAVE Health Inc?
Mr. Morgan Frank es el Chairman of the Board de SANUWAVE Health Inc, se unió a la empresa desde 2022.
¿Qué tal es el rendimiento del precio de la acción SNWV?
El precio actual de SNWV es de $18.41, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de SANUWAVE Health Inc?
SANUWAVE Health Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de SANUWAVE Health Inc?
La capitalización bursátil actual de SANUWAVE Health Inc es $158.1M
¿Es SANUWAVE Health Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 4 analistas han realizado calificaciones de análisis para SANUWAVE Health Inc, incluyendo 2 fuerte compra, 5 compra, 1 mantener, 0 venta, y 2 fuerte venta